Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Significant Decline in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a large decline in short interest in November. As of November 30th, there was short interest totalling 9,100 shares, a decline of 53.6% from the November 15th total of 19,600 shares. Currently, 0.7% of the company’s stock are sold short. Based on an average daily volume of 1,140,000 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. HC Wainwright reissued a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a research note on Wednesday, August 21st. StockNews.com started coverage on Arcadia Biosciences in a research report on Monday, December 9th. They set a “sell” rating for the company.

Arcadia Biosciences Stock Performance

Shares of RKDA stock remained flat at $6.30 during trading on Friday. 100,984 shares of the stock were exchanged, compared to its average volume of 325,098. The stock has a market capitalization of $8.57 million, a P/E ratio of -1.47 and a beta of 1.18. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31. The firm’s 50 day moving average is $3.77 and its two-hundred day moving average is $3.21.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.